There is wide use of 5-fluorouracil (5-FU)-based chemotherapy in the treatment of CRC, and it was shown to significantly activate the NLRP3 inflammasome in myeloid-derived suppressor cells (MDSCs). The gene discussed is NLRP3; the disease is colorectal carcinoma.